We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLF icon
2751
Herbalife
HLF
$1.21B
$69K ﹤0.01%
1,316
-25,242
-95% -$1.26M
NBP
2752
NovaBridge Biosciences American Depositary Shares
NBP
$205M
$69K ﹤0.01%
826
+126
+18% +$8.31K
VCEL icon
2753
Vericel Corp
VCEL
$2.25B
$69K ﹤0.01%
1,319
-2,049
-61% -$117K
WEBL icon
2754
Direxion Daily Dow Jones Internet Bull 3X ETF
WEBL
$111M
$69K ﹤0.01%
+770
New +$57.5K
RAVN
2755
DELISTED
Raven Industries Inc
RAVN
$69K ﹤0.01%
1,186
-1,395
-54% -$60.7K
CHMA
2756
DELISTED
Chiasma, Inc. Common Stock
CHMA
$69K ﹤0.01%
14,667
+10,218
+230% +$38.5K
AKRO
2757
DELISTED
Akero Therapeutics
AKRO
$68K ﹤0.01%
2,752
+1,868
+211% +$52.5K
APPF icon
2758
AppFolio
APPF
$7.07B
$68K ﹤0.01%
485
-843
-63% -$117K
ISCV icon
2759
iShares Morningstar Small-Cap Value ETF
ISCV
$704M
$68K ﹤0.01%
+1,162
New +$68.4K
NXE icon
2760
NexGen Energy
NXE
$6.91B
$68K ﹤0.01%
16,553
+11,453
+225% +$48.8K
SANA icon
2761
Sana Biotechnology
SANA
$1B
$68K ﹤0.01%
3,466
+3,066
+767% +$69.5K
VNDA icon
2762
Vanda Pharmaceuticals
VNDA
$304M
$68K ﹤0.01%
3,174
-6,825
-68% -$122K
VSTM icon
2763
Verastem
VSTM
$615M
$68K ﹤0.01%
1,382
+379
+38% +$15.8K
WOOF icon
2764
Petco
WOOF
$765M
$68K ﹤0.01%
3,056
+2,550
+504% +$59.6K
ASTH icon
2765
Astrana Health
ASTH
$1.86B
$68K ﹤0.01%
1,083
-280
-21% -$10.4K
CTEV
2766
Claritev Corp
CTEV
$581M
$68K ﹤0.01%
178
-501
-74% -$155K
NAPA
2767
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$68K ﹤0.01%
3,119
-7,643
-71% -$149K
CCXI
2768
DELISTED
ChemoCentryx, Inc.
CCXI
$68K ﹤0.01%
5,075
+1,509
+42% +$37.2K
WLL
2769
DELISTED
Whiting Petroleum Corporation
WLL
$68K ﹤0.01%
1,239
-623
-33% -$26.8K
BGSF icon
2770
BGSF Inc
BGSF
$59.3M
$67K ﹤0.01%
5,458
-270
-5% -$3.51K
KOPN icon
2771
Kopin
KOPN
$780M
$67K ﹤0.01%
8,272
-18,881
-70% -$156K
NOVA
2772
DELISTED
Sunnova Energy
NOVA
$67K ﹤0.01%
1,787
-6,953
-80% -$231K
RLGT icon
2773
Radiant Logistics
RLGT
$390M
$67K ﹤0.01%
9,635
+3,503
+57% +$25.4K
PBIP
2774
DELISTED
Prudential Bancorp, Inc.
PBIP
$67K ﹤0.01%
4,872
+2,598
+114% +$36.2K
SRGA
2775
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$67K ﹤0.01%
1,605
+1,308
+440% +$67K
109 110
111
112 113

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.